Impact of pathogenic germline BRCA1/2 and PALB2 mutations and tumor aneuploidy in patients with HR+/HER2-metastatic breast cancer treated with CDK4/6 inhibitors

被引：0

作者：

Antras, Jesus Fuentes

El Ghamrasni, Samah

Zou, Jinfeng

Dou, Aaron

Elliott, Mitchell J.

Avery, Lisa

Bratman, Scott Victor

Cescon, David W.

Bedard, Philippe L.

机构：

[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[3] Princess Margaret Canc Ctr, Toronto, ON, Canada

[4] Univ Toronto, Univ Hlth Network, Dept Biostat, Toronto, ON, Canada

[5] Univ Toronto, Toronto, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1075

引用

页数：1